Free Trial

William Pickering Analyst Performance

Analyst at Sanford C. Bernstein

William Pickering is a stock analyst at Sanford C. Bernstein in the medical sector, covering 14 publicly traded companies. Over the past year, William Pickering has issued 33 stock ratings, including buy and hold recommendations. While full access to William Pickering's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights William Pickering's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
33 Last 0 Years
Buy Recommendations
48.00% 12 Buy Ratings
Companies Covered
14 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy48.0%12 ratings
Hold52.0%13 ratings
Sell0.0%0 ratings

Out of 25 total stock ratings issued by William Pickering at Sanford C. Bernstein, the majority (52.0%) have been Hold recommendations, followed by 48.0% Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
92.9% of companies on NASDAQ
13 companies
NYSE
7.1% of companies on NYSE
1 company

William Pickering, an analyst at Sanford C. Bernstein, currently covers 14 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
14 companies
100.0%

William Pickering of Sanford C. Bernstein specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
12 companies
85.7%
MED - DRUGS
1 company
7.1%
MED - GENERIC DRG
1 company
7.1%

William Pickering's Ratings History at Sanford C. Bernstein

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
5/13/2026Boost Price Target$13.99$17.00Market Perform
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
5/13/2026Boost Price Target$18.37$24.00Market Perform
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
5/13/2026Boost Price Target$52.83$56.00Market Perform
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
5/13/2026Lower Price Target$31.58$39.00Outperform
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
5/13/2026Set Price Target$31.58$39.00
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
5/13/2026Boost Price Target$78.24$46.00Market Perform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/5/2026Lower Price Target$429.85$572.00Outperform
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/5/2026Lower Price Target$53.66$82.00Outperform
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
4/14/2026Boost Price Target$3.04$3.85Market Perform
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
4/14/2026Boost Price Target$2.63$3.85Market Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4/8/2026Lower Price Target$762.65$921.00Outperform
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/25/2026Boost Price Target$61.51$94.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Reiterated Rating$487.66$577.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Reiterated Rating$201.18Market Perform
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Set Price Target$201.18$201.00
Biogen Inc. stock logo
BIIB
Biogen
2/3/2026Set Price Target$179.09$191.00
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
1/21/2026Set Price Target$31.99$41.00
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
1/20/2026Boost Price Target$30.97$41.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/12/2026Upgrade$463.86Outperform
Biogen Inc. stock logo
BIIB
Biogen
1/9/2026Boost Price Target$168.57$197.00Market Perform
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
12/11/2025Initiated Coverage$72.70$94.00Outperform
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
12/11/2025Initiated Coverage$74.51$94.00Outperform
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
12/9/2025Set Price Target$19.19$23.00
Biohaven Ltd. stock logo
BHVN
Biohaven
11/6/2025Reiterated Rating$8.31$9.00Market Perform
Biogen Inc. stock logo
BIIB
Biogen
11/3/2025Set Price Target$151.30$157.00
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
11/3/2025Set Price Target$53.57$88.00
Biogen Inc. stock logo
BIIB
Biogen
11/3/2025Boost Price Target$154.27$157.00Market Perform
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
11/3/2025Lower Price Target$53.57$88.00Outperform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
10/28/2025Set Price Target$14.79$14.50
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
10/28/2025Downgrade$14.79$14.50Market Perform
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
10/27/2025Downgrade$49.15$72.00Market Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/27/2025Boost Price Target$587.74$781.00Outperform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/29/2025Initiated Coverage$13.86$13.00Market Perform